DE3855236D1 - Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen - Google Patents
Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschenInfo
- Publication number
- DE3855236D1 DE3855236D1 DE3855236T DE3855236T DE3855236D1 DE 3855236 D1 DE3855236 D1 DE 3855236D1 DE 3855236 T DE3855236 T DE 3855236T DE 3855236 T DE3855236 T DE 3855236T DE 3855236 D1 DE3855236 D1 DE 3855236D1
- Authority
- DE
- Germany
- Prior art keywords
- people
- autoimmune diseases
- treating vital
- treating
- conjugated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1069—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
- A61K51/1033—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants against receptors for cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8570787A | 1987-08-17 | 1987-08-17 | |
PCT/US1988/002731 WO1989001340A1 (en) | 1987-08-17 | 1988-08-11 | Method for treating malignancy and autoimmune disorders in humans |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3855236D1 true DE3855236D1 (de) | 1996-05-30 |
Family
ID=22193428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3855236T Expired - Lifetime DE3855236D1 (de) | 1987-08-17 | 1988-08-11 | Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050207975A1 (de) |
EP (1) | EP0380542B1 (de) |
JP (1) | JP2581788B2 (de) |
AT (1) | ATE137119T1 (de) |
CA (1) | CA1325591C (de) |
DE (1) | DE3855236D1 (de) |
WO (1) | WO1989001340A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776093A (en) * | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
US5336489A (en) * | 1985-09-05 | 1994-08-09 | The Beth Israel Hospital Association | Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
JPH03503887A (ja) * | 1988-02-03 | 1991-08-29 | エクソウマ コーポレーション | 自己免疫疾患に対する抗t細胞イムノトキシンの治療的使用 |
US5276348A (en) * | 1992-06-09 | 1994-01-04 | Advanced Photonix, Inc. | Dot matrix pattern on photosensitive semi-conductor surface |
US5759546A (en) * | 1994-02-04 | 1998-06-02 | Weinberg; Andrew D. | Treatment of CD4 T-cell mediated conditions |
FI95441C (fi) * | 1994-05-31 | 1996-02-12 | Leiras Oy | Inhalointilaitteen lääkeainekammio |
KR100465820B1 (ko) * | 2002-04-16 | 2005-01-13 | 심대근 | 문짝용 플라스틱 판넬 및 그 제조 방법 |
ES2401136T3 (es) | 2002-11-15 | 2013-04-17 | Genmab A/S | Anticuerpos monoclonales humanos contra CD25 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US903723A (en) * | 1907-12-23 | 1908-11-10 | Nelson Hughes | Buckle. |
SU438419A1 (ru) * | 1968-05-31 | 1974-08-05 | Н. Б. Михеев, М. А. Грачева , А. И. Журба Институт биофизики | Способ получения коллоидного растворас иттрием-90 |
DE2011612C3 (de) * | 1970-03-11 | 1974-03-21 | Institut Medizinskoi Radiologii Amn Ssr, Ussr, Obninsk (Sowjetunion) | Radionuklide enthaltende, resorbierbare Fäden und Filme |
US4709015A (en) * | 1979-12-04 | 1987-11-24 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human suppressor T cells |
US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
US4485093A (en) * | 1982-08-13 | 1984-11-27 | Runge Richard G | Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer |
US4550086A (en) * | 1983-02-16 | 1985-10-29 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibodies that recognize human T cells |
US4819150A (en) * | 1985-04-05 | 1989-04-04 | Unisys Corporation | Array for simulating computer functions for large computer systems |
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
GB2188941B (en) * | 1986-04-14 | 1990-06-06 | Bayer Ag | Monoclonal antibodies recognizing human interleukin-2-receptor |
FR2616330B1 (fr) * | 1987-06-12 | 1990-12-21 | Immunotech Sa | Agent actif et medicament en contenant destines a prevenir ou a combattre le rejet de greffe d'organe chez l'homme |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
-
1988
- 1988-08-11 JP JP63507708A patent/JP2581788B2/ja not_active Expired - Lifetime
- 1988-08-11 WO PCT/US1988/002731 patent/WO1989001340A1/en active IP Right Grant
- 1988-08-11 AT AT88908490T patent/ATE137119T1/de not_active IP Right Cessation
- 1988-08-11 DE DE3855236T patent/DE3855236D1/de not_active Expired - Lifetime
- 1988-08-11 EP EP88908490A patent/EP0380542B1/de not_active Expired - Lifetime
- 1988-08-17 CA CA000574976A patent/CA1325591C/en not_active Expired - Lifetime
-
2004
- 2004-12-06 US US11/005,575 patent/US20050207975A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE137119T1 (de) | 1996-05-15 |
WO1989001340A1 (en) | 1989-02-23 |
US20050207975A1 (en) | 2005-09-22 |
EP0380542B1 (de) | 1996-04-24 |
JPH03500645A (ja) | 1991-02-14 |
JP2581788B2 (ja) | 1997-02-12 |
CA1325591C (en) | 1993-12-28 |
EP0380542A1 (de) | 1990-08-08 |
EP0380542A4 (en) | 1990-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE190496T1 (de) | Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol | |
HUS1600042I1 (hu) | Anti-CS1 antitestek terápiás alkalmazása | |
HRP950052B1 (en) | Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels | |
ATE266417T1 (de) | Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien | |
DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
DE58902094D1 (de) | Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen. | |
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
DE3855236D1 (de) | Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen | |
ES2054484T3 (es) | Composiciones farmaceuticas que contienen complejos de antigeno-anticuerpo, asi como la utilizacion de las mismas. | |
ATE442157T1 (de) | Verwendung von anti-cd3 monoklonale antikírper und il-5 zur behandlung von autoimmunkrankheiten | |
DE3875306D1 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
ATE167628T1 (de) | Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion | |
DE3786173T2 (de) | Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten. | |
ATE108664T1 (de) | Verfahren zur verhütung von gvhd. | |
GR75239B (de) | ||
BE895861A (fr) | Agent therapeutique pour le traitement de troubles allergiques, de maladies a complexes immunitaires et de tumeurs | |
ATE75410T1 (de) | Verfahren und vorrichtung zur behandlung von krankheiten. | |
ES8300477A1 (es) | Procedimiento para la preparacion de una composicion para el tratamiento del cancer | |
PT75226B (en) | Method for diagnosing and for the therapeutic treatment of tu- mors diseases | |
ATE99174T1 (de) | Verfahren zur behandlung von gefaesskrankheiten. | |
IL66086A0 (en) | Method and apparatus for the treatment of autoimmune diseases and allergy | |
CS729987A1 (en) | Murine lymphocyte hybridoma fe 6 that produces antibody against human fibrin's fragments and method of its preparation | |
ATE101054T1 (de) | Einrichtung zur diagnostik und behandlung von nasenerkrankungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |